New User? Sign Up | Sign In

Insider Trading - Schwartz Jeffrey Lawrence

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Schwartz Jeffrey Lawrence

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-11-19
Sale
2019-11-21
4:26 pm
Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
1,750,000 $22.03 $38,552,501 5,580,237
(Indirect)
View
2019-09-17
Purchase
2019-09-19
7:05 pm
SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
150,000 $18 $2,700,000 7,281,307
(Indirect)
View
2019-05-29
Sale
2019-05-31
4:15 pm
Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
Director, 10% Owner
1,600,000 $12.5 $20,000,000 7,330,237
(Indirect)
View
2018-07-24
Purchase
2018-07-26
4:27 pm
Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
500,000 $15 $7,500,000 2,838,968
(Indirect)
View
2017-12-15
Sale
2017-12-19
8:30 pm
MARINUS PHARMACEUTICALS INC MRNS Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
1,272,547 $7.878 $10,024,801 4,530,335
(Indirect)
View
2017-12-18
Purchase
2017-12-19
4:52 pm
Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
Director, 10% Owner
285,000 $7 $1,995,000 8,930,237
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-09-17
Conversion
2019-09-19
7:05 pm
N/A
N/A
SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
6,078,103 $0 7,281,307
(Indirect)
View
2019-09-17
Conversion
2019-09-19
7:05 pm
N/A
N/A
SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
1,053,204 $0 7,281,307
(Indirect)
View
2019-09-17
Conversion
2019-09-19
7:05 pm
N/A
N/A
SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
6,078,103 $0 7,281,307
(Indirect)
View
2019-09-17
Conversion
2019-09-19
7:05 pm
N/A
N/A
SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
1,053,204 $0 7,281,307
(Indirect)
View
2019-03-29
Option Award
2019-09-16
7:52 pm
N/A
2029-09-12
SpringWorks Therapeutics Inc. SWTX Schwartz Jeffrey Lawrence
Director, 10% Owner
29,983 $18 6,078,103
(Direct)
View
2019-03-29
Option Award
2019-09-16
7:52 pm
N/A
N/A
SpringWorks Therapeutics Inc. SWTX Schwartz Jeffrey Lawrence
Director, 10% Owner
40,000,000 $0 6,078,103
(Indirect)
View
2019-03-29
Option Award
2019-09-16
7:52 pm
N/A
N/A
SpringWorks Therapeutics Inc. SWTX Schwartz Jeffrey Lawrence
Director, 10% Owner
6,931,142 $0 6,078,103
(Indirect)
View
2018-07-24
Conversion
2018-07-26
4:27 pm
N/A
N/A
Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
2,338,968 $0 2,838,968
(Indirect)
View
2018-07-24
Conversion
2018-07-26
4:27 pm
N/A
N/A
Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
235,146 $0 2,838,968
(Indirect)
View
2017-12-18
Exercise
2017-12-19
4:52 pm
N/A
N/A
Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
Director, 10% Owner
8,454,388 $0 8,930,237
(Indirect)
View
2017-12-18
Option Award
2017-12-19
4:52 pm
N/A
N/A
Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
Director, 10% Owner
190,849 $0 8,930,237
(Indirect)
View
2017-12-18
Exercise
2017-12-19
4:52 pm
N/A
N/A
Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
Director, 10% Owner
250,000 $3.19 8,930,237
(Indirect)
View